Cell cycle-related kinase in carcinogenesis (Review)

Tian,Ye; Wan,Han; Tan,Guang

doi:10.3892/ol.2012.828

Cell cycle-related kinase in carcinogenesis (Review)

Authors:
- Ye Tian
- Han Wan
- Guang Tan
View Affiliations

Affiliations: Department of General Surgery, First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116011, P.R. China
Published online on: July 27, 2012 https://doi.org/10.3892/ol.2012.828
Pages: 601-606

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cell cycle-related kinase (CCRK) is a novel protein kinase homologous to both cyclin-dependent kinase 7 (Cdk7) and Cak1p groups of CDK-activating kinase (CAK). CCRK activates Cdk2, which controls the cell-cycle progression by phosphorylating a threonine residue conserved in Cdk2. Previous studies have indicated that the CCRK protein levels were elevated by more than 1.5-fold in tumor tissue, and that the overexpression of CCRK is associated with poor prognosis of the patients. Moreover, recent studies have shown that CCRK is involved in the Wnt signaling pathway associated with the genesis and evolution of cancer. This review aims to systematically present the information currently available on CCRK obtained from in vitro and in vivo studies and highlight its significance to tumorigenesis.

View Figures

View References

1.	DR GreenGI EvanA matter of life and deathCancer Cell11930200210.1016/S1535-6108(02)00024-7
2.	Y ZwangM OrenY YardenConsistency test of the cell cycle: roles for p53 and EGR1Cancer Res7210511054201210.1158/0008-5472.CAN-11-338222315347
3.	J CicenasM ValiusThe CDK inhibitors in cancer research and therapyJ Cancer Res Clin Oncol13714091418201110.1007/s00432-011-1039-421877198
4.	J PinesFour-dimensional control of the cell cycleNat Cell Biol1E73E79199910.1038/1104110559915
5.	S OrtegaM MalumbresM BarbacidCyclin D-dependent kinases, INK4 inhibitors and cancerBiochim Biophys Acta16027387200211960696
6.	K MitraC WunderB RoysamG LinJ Lippincott-SchwartzA hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phaseProc Natl Acad Sci USA1061196011965200910.1073/pnas.090487510619617534
7.	D CobrinikPocket proteins and cell cycle controlOncogene2427962809200510.1038/sj.onc.120861915838516
8.	G LolliLN JohnsonCAK-cyclin-dependent activating kinase: a key kinase in cell cycle control and a target for drugs?Cell Cycle4572577200510.4161/cc.4.4.160715876871
9.	A SuttonR FreimanThe Cak1p protein kinase is required at G1/S and G2/M in the budding yeast cell cycleGenetics147577119979286668
10.	MR WallenfangG Seydouxcdk-7 is required for mRNA transcription and cell cycle progression in Caenorhabditis elegans embryosProc Natl Acad Sci USA9955275532200210.1073/pnas.08261839911960010
11.	X AnSS NgD XieFunctional characterisation of cell cycle-related kinase (CCRK) in colorectal cancer carcinogenesisEur J Cancer4617521761201010.1016/j.ejca.2010.04.00720466538
12.	S LarochelleJ PandurRP FisherHK SalzB SuterCdk7 is essential for mitosis and for in vivo Cdk-activating kinase activityGenes Dev12370381199810.1101/gad.12.3.3709450931
13.	H CleversWnt/beta-catenin signaling in development and diseaseCell127469480200610.1016/j.cell.2006.10.01817081971
14.	BT MacDonaldK TamaiX HeWnt/beta-catenin signaling: components, mechanisms, and diseasesDev Cell17926200910.1016/j.devcel.2009.06.01619619488
15.	W YangHX YanL ChenWnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cellsCancer Res6842874295200810.1158/0008-5472.CAN-07-669118519688
16.	Y YingQ TaoEpigenetic disruption of the WNT/beta-catenin signaling pathway in human cancersEpigenetics4307312200910.4161/epi.4.5.937119633433
17.	H FengAS ChengDP TsangCell cycle-related kinase is a direct androgen receptor-regulated gene that drives beta-catenin/T cell factor-dependent hepatocarcinogenesisJ Clin Invest12131593175201110.1172/JCI4596721747169
18.	P KaldisMJ SolomonAnalysis of CAK activities from human cellsEur J Biochem26742134221200010.1046/j.1432-1327.2000.01455.x10866826
19.	L WohlboldS LarochelleJC LiaoG LivshitsJ SingerKM ShokatRP FisherThe cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activityCell Cycle5546554200610.4161/cc.5.5.254116552187
20.	Y LiuC WuK Galaktionovp42, a novel cyclin-dependent kinase-activating kinase in mammalian cellsJ Biol Chem27945074514200410.1074/jbc.M30999520014597612
21.	SS NgYT CheungXM AnCell cycle-related kinase: a novel candidate oncogene in human glioblastomaJ Natl Cancer Inst99936948200710.1093/jnci/djm01117565152
22.	H QiuH DaiK JainR ShahC HongJ PainB TianDE VatnerSF VatnerC DepreCharacterization of a novel cardiac isoform of the cell cycle-related kinase that is regulated during heart failureJ Biol Chem2832215722165200810.1074/jbc.M71045920018508765
23.	GQ WuD XieGF YangYJ LiaoSJ MaiHX DengJ SzeXY GuanYX ZengMC LinHF KungCell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinomaInt J Cancer12526312642200910.1002/ijc.2463019672860
24.	Y YangY HuHY GuN LuW LiuQ QiL ZhaoXT WangQD YouQL GuoOroxylin A induces G2/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cellsJ Pharm Pharmacol6014591463200810.1211/jpp.60.11.000618957166
25.	J YuQL GuoQD YouL ZhaoHY GuY YangHW ZhangZ TanX WangGambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cellsCarcinogenesis28632638200710.1093/carcin/bgl16817012222
26.	V KrystofS UldrijanCyclin-dependent kinase inhibitors as anticancer drugsCurr Drug Targets11291302201010.2174/13894501079071195020210754
27.	J Węsierska-GądekM MaurerPromotion of apoptosis in cancer cells by selective purine-derived pharmacological CDK inhibitors: one outcome, many mechanismsCurr Pharm Des17256271201121348827
28.	JM EglyF CoinA history of TFIIH: two decades of molecular biology on a pivotal transcription/repair factorDNA Repair (Amst)10714721201110.1016/j.dnarep.2011.04.02121592869
29.	SA PatelMC SimonFunctional analysis of the Cdk7.cyclin H.Mat1 complex in mouse embryonic stem cells and embryosJ Biol Chem2851558715598201010.1074/jbc.M109.08168720231280
30.	K Glover-CutterS LarochelleB EricksonC ZhangK ShokatRP FisherDL BentleyTFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase IIMol Cell Biol2954555464200910.1128/MCB.00637-0919667075
31.	RP FisherSecrets of a double agent: CDK7 in cell-cycle control and transcriptionJ Cell Sci11851715180200510.1242/jcs.0271816280550
32.	S LarochelleKA MerrickME TerretL WohlboldNM BarbozaC ZhangKM ShokatPV JallepalliRP FisherRequirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cellsMol Cell25839850200710.1016/j.molcel.2007.02.00317386261
33.	P PillaiS DesaiR PatelM SajanR FareseD OstrovM Acevedo-DuncanA novel PKC-iota inhibitor abrogates cell proliferation and induces apoptosis in neuroblastomaInt J Biochem Cell Biol43784794201110.1016/j.biocel.2011.02.00221315177
34.	L BicaJ MeyerowitzSJ ParkerA CaragounisT DuBM PatersonKJ BarnhamPJ CrouchAR WhitePS DonnellyCell cycle arrest in cultured neuroblastoma cells exposed to a bis(thiosemicarbazonato) metal complexBiometals24117133201110.1007/s10534-010-9380-720931265
35.	RP FisherDO MorganA novel cyclin associates with MO15/CDK7 to form the CDK-activating kinaseCell78713724199410.1016/0092-8674(94)90535-58069918
36.	G LolliLN JohnsonRecognition of Cdk2 by Cdk7Proteins6710481059200710.1002/prot.2137017373709
37.	H NagaharaSA EzhevskyAM Vocero-AkbaniP KaldisMJ SolomonSF DowdyTransforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activityProc Natl Acad Sci USA961496114966199910.1073/pnas.96.26.1496110611320
38.	Z FuKA LarsonRK ChittaIdentification of yin-yang regulators and a phosphorylation consensus for male germ cell-associated kinase (MAK)-related kinaseMol Cell Biol2686398654200610.1128/MCB.00816-0616954377
39.	RM MarshallX GranaMechanisms controlling CDK9 activityFront Biosci1125982613200610.2741/199416720337
40.	WH YangJH HeatonH BrevigS MukherjeeJA Iñiguez-LluhíGD HammerSUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylationMol Cell Biol29613625200910.1128/MCB.00295-0819015234
41.	UM SachdevaJM O'BrienUnderstanding pRb: toward the necessary development of targeted treatments for retinoblastomaJ Clin Invest122425434201210.1172/JCI5711422293180
42.	V KolupaevaC BasilicoOverexpression of cyclin E/CDK2 complexes overcomes FGF-induced cell cycle arrest in the presence of hypophosphorylated Rb proteinsCell CycleJul.12012(E-pub ahead of print).
43.	P MeraldiJ LukasAM FryJ BartekEA NiggCentrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin ANat Cell Biol18893199910.1038/1005410559879
44.	M StamatakosV PallaI KaraiskosK XiromeritisI AlexiouI PaterasK KontzoglouCell cyclins: triggering elements of cancer or not?World J Surg Oncol8111201010.1186/1477-7819-8-11121176227
45.	RA WeinbergThe retinoblastoma protein and cell cycle controlCell81323330199510.1016/0092-8674(95)90385-27736585
46.	L XiaD RobinsonAH MaHC ChenF WuY QiuHJ KungIdentification of human male germ cell-associated kinase, a kinase transcriptionally activated by androgen in prostate cancer cellsJ Biol Chem2773542235433200210.1074/jbc.M20394020012084720
47.	F DesmotsHR RussellY LeeK BoydPJ McKinnonThe reaper-binding protein scythe modulates apoptosis and proliferation during mammalian developmentMol Cell Biol251032910337200510.1128/MCB.25.23.10329-10337.200516287848
48.	F DesmotsHR RussellD MichelPJ McKinnonScythe regulates apoptosis-inducing factor stability during endoplasmic reticulum stress-induced apoptosisJ Biol Chem28332643271200810.1074/jbc.M706419200
49.	R MinamiM ShimadaH YokosawaH KawaharaScythe regulates apoptosis through modulating ubiquitin-mediated proteolysis of the Xenopus elongation factor XEF1AOBiochem J405495501200710.1042/BJ2006188617428197
50.	T GoldenM SwingleRE HonkanenThe role of serine/threonine protein phosphatase type 5 (PP5) in the regulation of stress-induced signaling networks and cancerCancer Metastasis Rev27169178200810.1007/s10555-008-9125-z
51.	BM HamH JayachandranF YangNovel Ser/Thr protein phosphatase 5 (PP5) regulated targets during DNA damage identified by proteomics analysisJ Proteome Res9945953201010.1021/pr900820720039704
52.	AH MaL XiaSJ DesaiDL BoucherY GuanHM ShihXB ShiRW deVere WhiteHW ChenCG TepperHJ KungMale germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cellsCancer Res6684398447200610.1158/0008-5472.CAN-06-163616951154
53.	SP BalkKE KnudsenAR, the cell cycle, and prostate cancerNucl Recept Signal6e001200818301781
54.	M KalraJ MayesS AssefaAK KaulR KaulRole of sex steroid receptors in pathobiology of hepatocellular carcinomaWorld J Gastroenterol1459455961200810.3748/wjg.14.594518932272
55.	N AminE VincanThe Wnt signaling pathways and cell adhesionFront Biosci17784804201210.2741/3957
56.	RS TaraporeIA SiddiquiH MukhtarModulation of Wnt/beta-catenin signaling pathway by bioactive food componentsCarcinogenesis33483491201210.1093/carcin/bgr30522198211
57.	D KimelmanW Xubeta-catenin destruction complex: insights and questions from a structural perspectiveOncogene2574827491200610.1038/sj.onc.121005517143292
58.	DM RobertsMI PronobisJS PoultonJD WaldmannEM StephensonS HannaM PeiferDeconstructing the β-catenin destruction complex: mechanistic roles for the tumor suppressor APC in regulating Wnt signalingMol Biol Cell22184518632011
59.	A KikuchiH YamamotoA SatoS MatsumotoNew insights into the mechanism of Wnt signaling pathway activationInt Rev Cell Mol Biol2912171201110.1016/B978-0-12-386035-4.00002-122017973
60.	CY LoganR NusseThe Wnt signaling pathway in development and diseaseAnnu Rev Cell Dev Biol20781810200410.1146/annurev.cellbio.20.010403.11312615473860
61.	S WhittakerR MaraisAX ZhuThe role of signaling pathways in the development and treatment of hepatocellular carcinomaOncogene2949895005201010.1038/onc.2010.23620639898
62.	X TanU ApteA MicsenyiE KotsagrelosJH LuoS RanganathanDK MongaA BellGK MichalopoulosSP MongaEpidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liverGastroenterology129285302200510.1053/j.gastro.2005.04.01316012954
63.	JL BuescherCJ PhielA noncatalytic domain of glycogen synthase kinase-3 (GSK-3) is essential for activityJ Biol Chem28579577963201010.1074/jbc.M109.09160320080974
64.	P Uysal-OnganerRM KyptaWnt11 in 2011 - the regulation and function of a non-canonical WntActa Physiol (Oxf)2045264201210.1111/j.1748-1716.2011.02297.x21447091
65.	V GordonS BhadelW WunderlichCDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylationMol Endocrinol2422672280201010.1210/me.2010-023820980437
66.	JK KimJA DiehlNuclear cyclin D1: an oncogenic driver in human cancerJ Cell Physiol220292296200910.1002/jcp.2179119415697
67.	EA MusgroveCE CaldonJ BarracloughA StoneRL SutherlandCyclin D as a therapeutic target in cancerNat Rev Cancer11558572201110.1038/nrc309021734724
68.	AR NebredaCDK activation by non-cyclin proteinsCurr Opin Cell Biol18192198200610.1016/j.ceb.2006.01.00116488127
69.	T AbbasA DuttaCDK2-activating kinase (CAK): more questions than answersCell Cycle511231124200610.4161/cc.5.10.281916687928